Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. La Carrubba (PAVIA, Italy), L. Cavagna (PAVIA, Italy), E. Marasco (PAVIA, Italy), G. Zanframundo (PAVIA, Italy), A. Valentini (PAVIA, Italy), V. Morandi (PAVIA, Italy), V. Codullo (PARIS, France), L. Volpiano (PAVIA, Italy), F. Motta (PAVIA, Italy), C. Montecucco (PAVIA, Italy), F. Meloni (PAVIA, Italy). Prognostic impact and clinical characteristics of Interstitial Pneumonia with Autoimmune features (IPAF) in a multidisciplinary setting. 3674

Member's Comments

No comment yet.

Related content which might interest you: Interstitial Pneumonia with Autoimmune Features (IPAF): a single center prospective experience Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Interstitial pneumonia with autoimmune features (IPAF): a clinical entity? Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Severe sarcoidosis: clinical features and management Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): clinical heterogeneity and outcome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF) Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Sarcoidosis: Clinical course and prognostic predictors Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): Clinical, serological and radiological heterogeneity Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Management of sarcoidosis in clinical practice Source: Eur Respir Rev 2016; 25: 141-150 Year: 2016 The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 ANCA associated vasculitis – Evaluation of diagnosis, treatment and outcome in a group of 68 patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Acute Pulmonary Embolism in COPD patients, clinical features and outcomes Source: International Congress 2017 – Pulmonary embolism Year: 2017 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Interstitial pneumonia with autoimmune features: a new classification still on the move Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018 Year: 2018 Prognostic significance of clinical and morphological features in idiopathic interstitial pneumonias Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Severe asthma: Clinical features and management in Tunisia Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011 Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021